Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis (Q34530392)

2 August 2017

title

Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis (English)

1 reference

2 August 2017

1 reference

3

Jewell DP

1 reference

2 August 2017

Ireland A

1

1 reference

2 August 2017

Mason CH

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1988

1 reference

2 August 2017

1 reference

2 August 2017

volume

29

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

835-837

1 reference

Sulfasalazine. Adverse effects and desensitization

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

Olsalazine in active ulcerative colitis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

Effects of olsalazine in the jejunum of the rat.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

An experiment to determine the active therapeutic moiety of sulphasalazine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

Biopsy studies in ulcerative colitis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

Cortisone in ulcerative colitis; final report on a therapeutic trial.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433723

Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2898422

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2898422

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.29.6.835

1 reference

2 August 2017

1 reference

2 August 2017

1 reference